In the high‐B7‐H3 group, several cancer hallmarks including angiogenesis, apical junction, EMT, hypoxia, inflammatory response, and Wnt/beta‐catenin signaling, were significantly enriched in comparison with the low‐B7‐H3 group (Figure 4D). The gene discussed is CD80; the disease is cancer.